US Stock MarketDetailed Quotes

IRWD Ironwood Pharmaceuticals

Watchlist

8.220
+0.470+6.06%

Close May 1 16:00 ET

8.180
-0.040-0.49%

Post 17:37 ET

1.31BMarket Cap-1274P/E (TTM)

Ironwood Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.98%183.45M

-54.70%35.86M

-53.02%32.46M

-43.02%34.96M

25.02%80.17M

4.53%273.75M

22.65%79.16M

-7.96%69.09M

26.35%61.37M

-12.99%64.12M

Net income from continuing operations

-689.24%-1.03B

-103.57%-1.75M

-72.28%13.95M

-3,038.18%-1.09B

17.82%45.71M

-66.87%175.07M

18.11%48.87M

-9.90%50.32M

-90.52%37.08M

-2.82%38.8M

Operating gains losses

89.44%-19K

--0

97.40%-19K

-114.16%-180K

-99.22%20K

92.77%-151K

-78.49%681K

69.24%-730K

Depreciation and amortization

14.29%1.6M

66.77%537K

39.67%507K

-25.00%270K

-19.44%286K

-6.67%1.4M

-4.17%322K

1.40%363K

-9.09%360K

-13.41%355K

Deferred tax

10.49%72.64M

55.60%31.32M

-10.99%14.26M

-32.77%10.01M

15.94%17.05M

119.72%65.74M

941.33%20.13M

522.46%16.02M

104.41%14.89M

--14.71M

Other non cash items

58,557.62%1.1B

1,230.62%5.56M

46.50%586K

211,321.32%1.09B

-25.14%402K

-92.19%1.87M

-93.23%418K

-93.37%400K

-91.30%516K

-90.78%537K

Change In working capital

299.96%11.28M

-500.23%-8.55M

3.54%-4.75M

1,105.88%14.97M

120.10%9.61M

-84.10%2.82M

-64.99%2.14M

-180.21%-4.92M

106.53%1.24M

-82.20%4.36M

-Change in receivables

-88.44%924K

-588.47%-4.58M

61.25%-5.56M

-207.60%-3.24M

-22.22%14.3M

3.64%7.99M

107.55%937K

-4,405.71%-14.34M

119.76%3.01M

-47.54%18.38M

-Change in prepaid assets

30.89%4.22M

270.66%6.1M

54.36%4.39M

-97.34%-2.6M

-7,022.64%-3.67M

436.44%3.22M

0.80%1.65M

37.36%2.84M

7.25%-1.32M

103.15%53K

-Change in payables and accrued expense

134.69%6.51M

-186.92%-6.95M

-169.96%-2.79M

751.49%17.93M

90.44%-1.68M

-265.18%-18.75M

-113.25%-2.42M

6.31%3.99M

-30.92%-2.75M

-104.65%-17.57M

-Change in other current assets

-24.46%1.12M

13.13%405K

-18.90%279K

-85.89%58K

2.45%376K

26.60%1.48M

110.59%358K

2.99%344K

17.77%411K

16.14%367K

-Change in other current liabilities

-116.76%-1.49M

-317.81%-3.52M

-147.46%-1.06M

49.34%2.82M

-91.09%279K

385.89%8.88M

202.54%1.62M

727.45%2.24M

415.55%1.89M

646.77%3.13M

Cash from discontinued investing activities

Operating cash flow

-33.00%183.43M

-54.74%35.83M

-53.02%32.46M

-43.02%34.96M

25.02%80.17M

4.53%273.76M

22.63%79.18M

-7.96%69.09M

26.35%61.37M

-12.99%64.12M

Investing cash flow

Cash flow from continuing investing activities

-754,545.59%-1.03B

-15,611.11%-4.19M

-34,180.30%-22.63M

-1,135,686.36%-999.49M

-44.44%-13K

48.68%-136K

121.09%27K

51.82%-66K

-88K

-9K

Net PPE purchase and sale

-100.74%-273K

-881.48%-211K

25.76%-49K

--0

-44.44%-13K

48.68%-136K

121.09%27K

51.82%-66K

---88K

---9K

Net business purchase and sale

---1.03B

---3.98M

---22.58M

----

--0

----

Cash from discontinued investing activities

Investing cash flow

-754,545.59%-1.03B

-15,611.11%-4.19M

-34,180.30%-22.63M

-1,135,686.36%-999.49M

-44.44%-13K

48.68%-136K

121.09%27K

51.82%-66K

---88K

---9K

Financing cash flow

Cash flow from continuing financing activities

216.67%277.16M

-1,914.11%-50.9M

-9,508.78%-74.99M

365.55%399.07M

104.38%3.98M

-5,120.95%-237.55M

115.10%2.81M

-87.07%797K

-2,754.24%-150.28M

-4,210.04%-90.87M

Net issuance payments of debt

348.55%300M

---25M

---75M

----

---120.7M

--0

----

Net common stock issuance

--0

-423.78%-126.39M

--0

---33.9M

---92.5M

Proceeds from stock option exercised by employees

-33.36%6.36M

-64.43%998K

-98.49%12K

-68.34%1.37M

145.44%3.98M

-51.28%9.54M

-49.39%2.81M

-87.07%797K

-23.79%4.32M

-26.64%1.62M

Net other financing activities

---29.2M

---26.9M

--0

----

Cash from discontinued financing activities

Financing cash flow

216.67%277.16M

-1,914.11%-50.9M

-9,508.78%-74.99M

365.55%399.07M

104.38%3.98M

-5,120.95%-237.55M

115.10%2.81M

-87.07%797K

-2,754.24%-150.28M

-4,210.04%-90.87M

Net cash flow

Beginning cash position

5.80%657.94M

-80.65%111.46M

-65.10%176.62M

24.70%742.08M

5.80%657.94M

70.47%621.86M

-0.02%575.92M

2.26%506.1M

35.04%595.11M

70.47%621.86M

Current changes in cash

-1,668.25%-565.73M

-123.48%-19.26M

-193.31%-65.15M

-535.30%-565.46M

414.44%84.14M

-85.97%36.07M

78.87%82.02M

-13.90%69.82M

-264.13%-89.01M

-135.25%-26.76M

Effect of exchange rate changes

---53K

---50K

----

--0

----

End cash Position

-85.99%92.15M

-80.65%111.46M

-65.10%176.62M

24.70%742.08M

5.80%657.94M

-0.02%575.92M

2.26%506.1M

35.04%595.11M

Free cash flow

-33.06%183.15M

-55.03%35.62M

-53.05%32.41M

-42.94%34.96M

25.02%80.16M

4.59%273.63M

22.92%79.21M

-7.88%69.03M

26.17%61.28M

-13.00%64.12M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.98%183.45M	-54.70%35.86M	-53.02%32.46M	-43.02%34.96M	25.02%80.17M	4.53%273.75M	22.65%79.16M	-7.96%69.09M	26.35%61.37M	-12.99%64.12M
Net income from continuing operations	-689.24%-1.03B	-103.57%-1.75M	-72.28%13.95M	-3,038.18%-1.09B	17.82%45.71M	-66.87%175.07M	18.11%48.87M	-9.90%50.32M	-90.52%37.08M	-2.82%38.8M
Operating gains losses	89.44%-19K	--0	--0	--0	97.40%-19K	-114.16%-180K	-99.22%20K	92.77%-151K	-78.49%681K	69.24%-730K
Depreciation and amortization	14.29%1.6M	66.77%537K	39.67%507K	-25.00%270K	-19.44%286K	-6.67%1.4M	-4.17%322K	1.40%363K	-9.09%360K	-13.41%355K
Deferred tax	10.49%72.64M	55.60%31.32M	-10.99%14.26M	-32.77%10.01M	15.94%17.05M	119.72%65.74M	941.33%20.13M	522.46%16.02M	104.41%14.89M	--14.71M
Other non cash items	58,557.62%1.1B	1,230.62%5.56M	46.50%586K	211,321.32%1.09B	-25.14%402K	-92.19%1.87M	-93.23%418K	-93.37%400K	-91.30%516K	-90.78%537K
Change In working capital	299.96%11.28M	-500.23%-8.55M	3.54%-4.75M	1,105.88%14.97M	120.10%9.61M	-84.10%2.82M	-64.99%2.14M	-180.21%-4.92M	106.53%1.24M	-82.20%4.36M
-Change in receivables	-88.44%924K	-588.47%-4.58M	61.25%-5.56M	-207.60%-3.24M	-22.22%14.3M	3.64%7.99M	107.55%937K	-4,405.71%-14.34M	119.76%3.01M	-47.54%18.38M
-Change in prepaid assets	30.89%4.22M	270.66%6.1M	54.36%4.39M	-97.34%-2.6M	-7,022.64%-3.67M	436.44%3.22M	0.80%1.65M	37.36%2.84M	7.25%-1.32M	103.15%53K
-Change in payables and accrued expense	134.69%6.51M	-186.92%-6.95M	-169.96%-2.79M	751.49%17.93M	90.44%-1.68M	-265.18%-18.75M	-113.25%-2.42M	6.31%3.99M	-30.92%-2.75M	-104.65%-17.57M
-Change in other current assets	-24.46%1.12M	13.13%405K	-18.90%279K	-85.89%58K	2.45%376K	26.60%1.48M	110.59%358K	2.99%344K	17.77%411K	16.14%367K
-Change in other current liabilities	-116.76%-1.49M	-317.81%-3.52M	-147.46%-1.06M	49.34%2.82M	-91.09%279K	385.89%8.88M	202.54%1.62M	727.45%2.24M	415.55%1.89M	646.77%3.13M
Cash from discontinued investing activities
Operating cash flow	-33.00%183.43M	-54.74%35.83M	-53.02%32.46M	-43.02%34.96M	25.02%80.17M	4.53%273.76M	22.63%79.18M	-7.96%69.09M	26.35%61.37M	-12.99%64.12M
Investing cash flow
Cash flow from continuing investing activities	-754,545.59%-1.03B	-15,611.11%-4.19M	-34,180.30%-22.63M	-1,135,686.36%-999.49M	-44.44%-13K	48.68%-136K	121.09%27K	51.82%-66K	-88K	-9K
Net PPE purchase and sale	-100.74%-273K	-881.48%-211K	25.76%-49K	--0	-44.44%-13K	48.68%-136K	121.09%27K	51.82%-66K	---88K	---9K
Net business purchase and sale	---1.03B	---3.98M	---22.58M	----	----	--0	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-754,545.59%-1.03B	-15,611.11%-4.19M	-34,180.30%-22.63M	-1,135,686.36%-999.49M	-44.44%-13K	48.68%-136K	121.09%27K	51.82%-66K	---88K	---9K
Financing cash flow
Cash flow from continuing financing activities	216.67%277.16M	-1,914.11%-50.9M	-9,508.78%-74.99M	365.55%399.07M	104.38%3.98M	-5,120.95%-237.55M	115.10%2.81M	-87.07%797K	-2,754.24%-150.28M	-4,210.04%-90.87M
Net issuance payments of debt	348.55%300M	---25M	---75M	----	----	---120.7M	--0	--0	----	----
Net common stock issuance	--0	--0	--0	--0	--0	-423.78%-126.39M	--0	--0	---33.9M	---92.5M
Proceeds from stock option exercised by employees	-33.36%6.36M	-64.43%998K	-98.49%12K	-68.34%1.37M	145.44%3.98M	-51.28%9.54M	-49.39%2.81M	-87.07%797K	-23.79%4.32M	-26.64%1.62M
Net other financing activities	---29.2M	---26.9M	--0	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	216.67%277.16M	-1,914.11%-50.9M	-9,508.78%-74.99M	365.55%399.07M	104.38%3.98M	-5,120.95%-237.55M	115.10%2.81M	-87.07%797K	-2,754.24%-150.28M	-4,210.04%-90.87M
Net cash flow
Beginning cash position	5.80%657.94M	-80.65%111.46M	-65.10%176.62M	24.70%742.08M	5.80%657.94M	70.47%621.86M	-0.02%575.92M	2.26%506.1M	35.04%595.11M	70.47%621.86M
Current changes in cash	-1,668.25%-565.73M	-123.48%-19.26M	-193.31%-65.15M	-535.30%-565.46M	414.44%84.14M	-85.97%36.07M	78.87%82.02M	-13.90%69.82M	-264.13%-89.01M	-135.25%-26.76M
Effect of exchange rate changes	---53K	---50K	----	----	----	--0	--0	----	----	----
End cash Position	-85.99%92.15M	-85.99%92.15M	-80.65%111.46M	-65.10%176.62M	24.70%742.08M	5.80%657.94M	5.80%657.94M	-0.02%575.92M	2.26%506.1M	35.04%595.11M
Free cash flow	-33.06%183.15M	-55.03%35.62M	-53.05%32.41M	-42.94%34.96M	25.02%80.16M	4.59%273.63M	22.92%79.21M	-7.88%69.03M	26.17%61.28M	-13.00%64.12M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall